Parker B, Sukumar S: Distant metastasis in breast cancer: molecular mechanisms and therapeutic targets. Cancer Biol Ther. 2003, 2 (1): 14-21.
Article
PubMed
Google Scholar
Gong C, Yang B, Qian Z, Zhao X, Wu Q, Qi X, Wang Y, Guo G, Kan B, Luo F: Improving intraperitoneal chemotherapeutic effect and preventing postsurgical adhesions simultaneously with biodegradable micelles. Nanomedicine. 2012, 8 (6): 963-973. 10.1016/j.nano.2011.10.010.
CAS
PubMed
Google Scholar
Kataoka K, Harada A, Nagasaki Y: Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev. 2012, 47 (1): 113-131.
Article
Google Scholar
Zhang L, Gu F, Chan J, Wang A, Langer R, Farokhzad O: Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 2007, 83 (5): 761-769.
Article
PubMed
Google Scholar
Davis ME: Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008, 7 (9): 771-782. 10.1038/nrd2614.
Article
CAS
PubMed
Google Scholar
Dobrovolskaia MA, McNeil SE: Immunological properties of engineered nanomaterials. Nat Nanotechnol. 2007, 2 (8): 469-478. 10.1038/nnano.2007.223.
Article
CAS
PubMed
Google Scholar
Gradishar WJ, Tjulandin S, Davidson N, Shaw H, Desai N, Bhar P, Hawkins M, O'Shaughnessy J: Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil–based paclitaxel in women with breast cancer. J Clin Oncol. 2005, 23 (31): 7794-7803. 10.1200/JCO.2005.04.937.
Article
CAS
PubMed
Google Scholar
Wong C, Stylianopoulos T, Cui J, Martin J, Chauhan VP, Jiang W, Popović Z, Jain RK, Bawendi MG, Fukumura D: Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci. 2011, 108 (6): 2426-2431. 10.1073/pnas.1018382108.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jain RK, Stylianopoulos T: Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010, 7 (11): 653-664. 10.1038/nrclinonc.2010.139.
Article
CAS
PubMed
PubMed Central
Google Scholar
Volk LD, Flister MJ, Chihade D, Desai N, Trieu V, Ran S: Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastases. Neoplasia. 2011, 13 (4): 327-
Article
CAS
PubMed
PubMed Central
Google Scholar
O’brien M, Wigler N, Inbar M, Rosso R, Grischke E, Santoro A, Catane R, Kieback D, Tomczak P, Ackland S: Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX™/Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol. 2004, 15 (3): 440-449. 10.1093/annonc/mdh097.
Article
PubMed
Google Scholar
Fang J, Nakamura H, Maeda H: The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011, 63 (3): 136-151. 10.1016/j.addr.2010.04.009.
Article
CAS
PubMed
Google Scholar
Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, Langer R, Jacks T, Anderson DG: Treating metastatic cancer with nanotechnology. Nat Rev Cancer. 2011, 12 (1): 39-50. 10.1038/nrc3180.
Article
PubMed
Google Scholar
Peiris PM, Toy R, Doolittle E, Pansky J, Abramowski A, Tam M, Vicente P, Tran E, Hayden E, Camann A: Imaging metastasis using an integrin-targeting chain-shaped nanoparticle. ACS Nano. 2012, 6 (10): 8783-8795. 10.1021/nn303833p.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen SL, Iddings DM, Scheri RP, Bilchik AJ: Lymphatic mapping and sentinel node analysis: current concepts and applications. CA Cancer J Clin. 2006, 56 (5): 292-309. 10.3322/canjclin.56.5.292.
Article
PubMed
Google Scholar
Tammela T, Saaristo A, Holopainen T, Ylä-Herttuala S, Andersson LC, Virolainen S, Immonen I, Alitalo K: Photodynamic ablation of lymphatic vessels and intralymphatic cancer cells prevents metastasis. Sci Transl Med. 2011, 3 (69): 69ra11-69ra11.
Article
PubMed
Google Scholar
Weinberg RA: The biology of cancer, vol. 255. 2007, New York: Garland Science
Google Scholar
Anderson C, Jacobson G, Bhatia S, Buatti JM: Atlas of Diagnostic Oncology. Int J Radiat Oncol Biol Phys. 2011, 81 (1): 314-314. 10.1016/j.ijrobp.2011.04.021.
Article
Google Scholar
Tang N, Du G, Wang N, Liu C, Hang H, Liang W: Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin. J Natl Cancer Inst. 2007, 99 (13): 1004-1015. 10.1093/jnci/djm027.
Article
CAS
PubMed
Google Scholar
Qin L, Zhang F, Lu X, Wei X, Wang J, Fang X, Si D, Wang Y, Zhang C, Yang R: Polymeric micelles for enhanced lymphatic drug delivery to treat metastatic tumors. J Control Release. 2013, 171 (2): 133-142. 10.1016/j.jconrel.2013.07.005.
Article
CAS
PubMed
Google Scholar
Rafi M, Cabral H, Kano M, Mi P, Iwata C, Yashiro M, Hirakawa K, Miyazono K, Nishiyama N, Kataoka K: Polymeric micelles incorporating (1, 2-diaminocyclohexane) platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasis. J Control Release. 2012, 159 (2): 189-196. 10.1016/j.jconrel.2012.01.038.
Article
CAS
PubMed
Google Scholar
Wei X, Wang Y, Zeng W, Huang F, Qin L, Zhang C, Liang W: Stability Influences the Biodistribution, Toxicity, and Anti-tumor Activity of Doxorubicin Encapsulated in PEG-PE Micelles in Mice. Pharm Res. 2012, 29 (7): 1977-1989. 10.1007/s11095-012-0725-5.
Article
CAS
PubMed
Google Scholar
Bae YH, Yin H: Stability issues of polymeric micelles. J Control Release. 2008, 131 (1): 2-4. 10.1016/j.jconrel.2008.06.015.
Article
CAS
PubMed
Google Scholar
Wang Y, Wang R, Lu X, Lu W, Zhang C, Liang W: Pegylated phospholipids-based self-assembly with water-soluble drugs. Pharm Res. 2010, 27 (2): 361-370. 10.1007/s11095-009-0029-6.
Article
CAS
PubMed
Google Scholar
Rowinsky EK, Donehower RC: Paclitaxel (Taxol). N Engl J Med. 1995, 332 (15): 1004-1014. 10.1056/NEJM199504133321507.
Article
CAS
PubMed
Google Scholar
Miller KD, Sledge GW: Taxanes in the Treatment of Breast Cancer: A Prodigy Comes of Age. Cancer Invest. 1999, 17 (2): 121-136. 10.3109/07357909909011727.
Article
CAS
PubMed
Google Scholar
Bhalla KN: Microtubule-targeted anticancer agents and apoptosis. Oncogene. 2003, 22 (56): 9075-9086. 10.1038/sj.onc.1207233.
Article
CAS
PubMed
Google Scholar
CHABNER BA LONGODL: Cancer chemotherapy & biotherapy. Principles & practice. 2001
Google Scholar
Jones S: Head-to-head: docetaxel challenges paclitaxel. Eur J Cancer Suppl. 2006, 4 (4): 4-8. 10.1016/S1359-6349(06)80002-9.
Article
CAS
Google Scholar
Araque Arroyo P, Ubago Pérez R, Cancela Díez B, Fernández Feijóo MA, Hernández Magdalena J, Calleja Hernández MA: Controversies in the management of adjuvant breast cancer with taxanes: Review of the current literature. Cancer Treat Rev. 2011, 37 (2): 105-110. 10.1016/j.ctrv.2010.06.002.
Article
CAS
PubMed
Google Scholar
Kim D-W, Kim S-Y, Kim H-K, Kim S-W, Shin S, Kim J, Park K, Lee M, Heo D: Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann Oncol. 2007, 18 (12): 2009-2014. 10.1093/annonc/mdm374.
Article
PubMed
Google Scholar
Kim SC, Kim DW, Shim YH, Bang JS, Oh HS, Kim SW, Seo MH: In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release. 2001, 72 (1): 191-202.
Article
CAS
PubMed
Google Scholar
Kim T-Y, Kim D-W, Chung J-Y, Shin SG, Kim S-C, Heo DS, Kim NK, Bang Y-J: Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin Cancer Res. 2004, 10 (11): 3708-3716. 10.1158/1078-0432.CCR-03-0655.
Article
CAS
PubMed
Google Scholar
Lee KS, Chung HC, Im SA, Park YH, Kim CS, Kim S-B, Rha SY, Lee MY, Ro J: Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer. Breast Cancer Res Treat. 2008, 108 (2): 241-250. 10.1007/s10549-007-9591-y.
Article
CAS
PubMed
Google Scholar
Zhang X, Jackson JK, Burt HM: Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int J Pharm. 1996, 132 (1): 195-206.
Article
CAS
Google Scholar
Liggins R, Burt H: Polyether–polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Adv Drug Deliv Rev. 2002, 54 (2): 191-202. 10.1016/S0169-409X(02)00016-9.
Article
CAS
PubMed
Google Scholar
Pulaski BA, Ostrand‒Rosenberg S: Mouse 4T1 breast tumor model. Curr Protoc Immunol. 2001, 20.22. 21-20.22. 16.
Google Scholar
Eckhardt BL, Francis PA, Parker BS, Anderson RL: Strategies for the discovery and development of therapies for metastatic breast cancer. Nat Rev Drug Discov. 2012, 11 (6): 479-497. 10.1038/nrd2372.
Article
CAS
PubMed
Google Scholar
Rashid OM, Nagahashi M, Ramachandran S, Graham L, Yamada A, Spiegel S, Bear HD, Takabe K: Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden. Surgery. 2013, 153 (6): 771-778. 10.1016/j.surg.2013.02.002.
Article
PubMed
PubMed Central
Google Scholar
Xiao L, Xiong X, Sun X, Zhu Y, Yang H, Chen H, Gan L, Xu H, Yang X: Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles. Biomaterials. 2011, 32 (22): 5148-5157. 10.1016/j.biomaterials.2011.03.071.
Article
CAS
PubMed
Google Scholar
Luo Y, Ling Y, Guo W, Pang J, Liu W, Fang Y, Wen X, Wei K, Gao X: Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells. J Control Release. 2010, 147 (2): 278-288. 10.1016/j.jconrel.2010.07.108.
Article
CAS
PubMed
Google Scholar
Tao K, Fang M, Alroy J, Sahagian GG: Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer. 2008, 8 (1): 228-10.1186/1471-2407-8-228.
Article
PubMed
PubMed Central
Google Scholar
Jenkins DE, Yu S-F, Hornig YS, Purchio T, Contag PR: In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3 M-luc-C6 cells in murine models of human prostate cancer. Clin Exp Metastasis. 2003, 20 (8): 745-756.
Article
PubMed
Google Scholar
Sheikh AY, Lin SA, Cao F, Cao Y, Van der Bogt KE, Chu P, Chang CP, Contag CH, Robbins RC, Wu JC: Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium. Stem Cells. 2007, 25 (10): 2677-2684. 10.1634/stemcells.2007-0041.
Article
PubMed
PubMed Central
Google Scholar
Joyce JA, Pollard JW: Microenvironmental regulation of metastasis. Nat Rev Cancer. 2008, 9 (4): 239-252.
Article
PubMed
PubMed Central
Google Scholar
Aslakson CJ, Miller FR: Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 1992, 52 (6): 1399-1405.
CAS
PubMed
Google Scholar
Pulaski BA, Smyth MJ, Ostrand-Rosenberg S: Interferon-γ-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma. Cancer Res. 2002, 62 (15): 4406-4412.
CAS
PubMed
Google Scholar
Harris J, Morrow M, Norton L: Malignant tumors of the breast. Cancer Principles Pract Oncol. 1997, 2: 1557-1616.
Google Scholar
Dykxhoorn DM, Wu Y, Xie H, Yu F, Lal A, Petrocca F, Martinvalet D, Song E, Lim B, Lieberman J: miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One. 2009, 4 (9): e7181-10.1371/journal.pone.0007181.
Article
PubMed
PubMed Central
Google Scholar
Harris J, Morrow M, Norton L: Malignant tumors of the breast. Cancer: Principles and Practice of Oncology Philadelphia, PA, Lippincott. 1997, 1557-1616.
Google Scholar
Ostrand-Rosenberg S, Sinha P: Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol. 2009, 182 (8): 4499-4506. 10.4049/jimmunol.0802740.
Article
CAS
PubMed
PubMed Central
Google Scholar
Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A: Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009, 30 (7): 1073-1081. 10.1093/carcin/bgp127.
Article
CAS
PubMed
Google Scholar